Lusedra Approval History

• FDA approved: Yes (First approved December 12th, 2008)
• Brand name: Lusedra
• Generic name: fospropofol disodium
• Previous name: Aquavan
• Company: Eisai Corporation of North America
• Treatment for: Sedation

Lusedra (fospropofol disodium) is an intravenous sedative-hypnotic agent for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.

FDA Approval History for Lusedra

Date	Article
Dec 15, 2008	FDA Approves Lusedra (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
Jul 28, 2008	Eisai Receives Action Letter on Fospropofol Disodium Injection for Sedation in Diagnostic or Therapeutic Procedures
Dec 17, 2007	MGI Pharma Announces Aquavan NDA Accepted for Review by U.S. FDA
Sep 27, 2007	MGI Pharma Announces Submission of Aquavan NDA

See also...

Lusedra (fospropofol disodium) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.